Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Completed 48Unknown 18Recruiting 16Terminated 8Active not recruiting 8Not yet recruiting 6Withdrawn 5Enrolling by invitation 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 3Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 3Melanoma 1Anus Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Sentinel Lymph Node Biopsy × Clear all
NCT01826864 2020-07-27

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma

Jonsson Comprehensive Cancer Center

Phase 3 Withdrawn
Dermatologic

Melanoma

NCT01796444 2018-04-05

Z0011-China

Shandong Cancer Hospital and Institute

Phase 3 Withdrawn
Breast

Breast Neoplasms

NCT02610621 2016-10-13

Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy

Cedars-Sinai Medical Center

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT02162641 2015-06-03

R-SeNSAR

The Christie NHS Foundation Trust

Withdrawn
Gastrointestinal

Anus Neoplasms

NCT00903214 2013-04-29

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡